T cell immune regulator 1 (TCIRG1), also known as T cell immune response cDNA7 (TIRC7), has been implicated in promoting progression and metastasis in malignancies, encompassing prostate cancer [29], breast cancer, and hepatocellular carcinoma [29–31]. Here, TCIRG1 is linked to prostate carcinoma.